Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Candesartan versus amlodipine for microvascular changes in essential hypertension
2008-005432-32Phase 4Terminated
- Sponsor
- St. George's University
- Start
- Apr 2009
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of candesartan and amlodipine in essential hypertension (2 arms), sponsored by St. George's University. Primary endpoint: Increase in maximal skin capillary density. Started Apr 2009; status: terminated.
02
Drugs
candesartanamlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2008-005432-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005432-32.